Rabeprazole specific clinical experience investigation for the long-term combination therapy with low-dose aspiri
Not Applicable
- Conditions
- Gastric ulcer, Duodenal ulcer
- Registration Number
- JPRN-jRCT1080222833
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 1400
Inclusion Criteria
(1)Patients taking long-term low-dose aspirin for prevention of thrombus/embolism at the start of administration of rabeprazole(including patients who start low-dose aspirin on the same day as the start of administration of rabeprazole)
(2)Patients with a history of gastric/duodenal ulcers
(3)Patients requiring long-term use of rabeprazole for prevention of recurrence of gastric/duodenal ulcers induced by low-dose aspirin
Exclusion Criteria
(1)Patients with gastric/duodenal ulcers at the start of administration of rabeprazole
(2)Patients with active upper gastrointestinal bleeding at the start of administration of rabeprazole
(3)Patients with contraindication for rabeprazole
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method